Modelling the early mass-ejection in jet driven protostellar outflows. Lessons from Cep E

We have used the axisymmetric chemo-hydrodynamical code WALKIMYA-2D to numerically model and reproduce the physical and CO emission properties of the jet-driven outflow from the intermediate-mass protostar Cep E, which was observed at $\sim 800$au resolution in the CO $J=2\to 1$ line with the IRAM interferometer. Our simulations take into account the observational constraints available on the physical structure of the protostellar envelope to provide constraints on the dynamics of the inner protostellar environment from the study of the outflow/jet propagation away from the launch region. WALKIMYA-2D successfully reproduces the main qualitative and quantitative features of the Cep E outflow and the jet kinematics, naturally accounting for their time variability. Signatures of internal shocks are detected as knots along the jet. In the early times of the ejection process, the young emitted knots interact with the dense circumstellar envelope through high-velocity, dissociative shocks, which strongly decrease the CO gas abundance in the jet. As time proceeds, the knots propagate more smoothly through the envelope and dissociative shocks disappear after $\sim 10^3$ yr. The distribution of CO abundance along the jet shows that the latter bears memory of the early dissociative phase in the course of its propagation. Analysis of the velocity field shows that the jet material mainly consists of gas entrained from the circumstellar envelope and accelerated away from the protostar at $700$ au scale. As a result, the overall jet mass loss rate appears higher than the actual mass ejection rate by a factor $\sim 3$. Numerical modeling of the Cep E jet-driven outflow and comparison with the CO observations have allowed us to peer into the outflow formation mechanism with unprecedented detail and to retrieve the history of the mass-loss events that have shaped the outflow

Modulated-laser source induction system for remote detection of infrared emissions of high explosives using laser-induced thermal emission

In a homeland security setting, the ability to detect explosives at a distance is a top security priority. Consequently, the development of remote, noncontact detection systems continues to represent a path forward. In this vein, a remote detection system for excitation of infrared emissions using a CO2 laser for generating laser-induced thermal emission (LITE) is a possible solution. However, a LITE system using a CO2 laser has certain limitations, such as the requirement of careful alignment, interference by the CO2 signal during detection, and the power density loss due to the increase of the laser image at the sample plane with the detection distance. A remote chopped-laser induction system for LITE detection using a CO2 laser source coupled to a focusing telescope was built to solve some of these limitations. Samples of fixed surface concentration (500 μg∕cm2) of 1,3,5-trinitroperhydro-1,3,5-triazine (RDX) were used for the remote detection experiments at distances ranging between 4 and 8 m. This system was capable of thermally exciting and capturing the thermal emissions (TEs) at different times in a cyclic manner by a Fourier transform infrared (FTIR) spectrometer coupled to a gold-coated reflection optics telescope (FTIR-GT). This was done using a wheel blocking the capture of TE by the FTIR-GT chopper while heating the sample with the CO2 laser. As the wheel moved, it blocked the CO2 laser and allowed the spectroscopic system to capture the TEs of RDX. Different periods (or frequencies) of wheel spin and FTIR-GT integration times were evaluated to find dependence with observation distance of the maximum intensity detection, minimum signal-to-noise ratio, CO2 laser spot size increase, and the induced temperature incremen

Stroke related mortality at different altitudes: A 17-year nationwide population-based analysis from Ecuador

Worldwide, more than 5.7% of the population reside above 1,500m of elevation. It has been hypothesized that acute short-term hypoxia exposure could increase the risk of developing a stroke. Studies assessing the effect of altitude on stroke have provided conflicting results, some analyses suggest that long-term chronic exposure could be associated with reduced mortality and lower stroke incidence rates. An ecological analysis of all stroke hospital admissions, mortality rates and disability-adjusted life years in Ecuador was performed from 2001-2017. The cases and population at risk were categorized in low (<1,500m), moderate (1,500m -2,500m), high (2,500m -3,500m) and very high altitude (3,500-5,500m) according to the place of residence. The derived crude and direct standardized age-sex adjusted mortality and hospital admission rates were calculated. A total of 38,201 deaths and 75,893 stroke-related hospital admissions were reported. High altitude populations (HAP) had lower stroke mortality in men (OR: 0.91 [0.88 - 0.95]) and women (OR: 0.83 [0.79 - 0.86]). In addition, HAP had a significant lower risk of getting admitted to the hospital when compared with the low altitude group in men (OR: 0.55 [CI95% 0.54 - 0.56]) and women (OR: 0.65 [CI95% [0.64 - 0.66]). This is the first epidemiological study that aims to elucidate the association between stroke and altitude using four different elevation ranges. Our findings suggest that living at higher elevations offers a reduction or the risk of dying due to stroke as well as a reduction in the probability of being admitted to the hospital. Nevertheless, this protective factor has a stronger effect between 2,000m to 3,500 m

Identification of circulating miRNA profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma

Accurate diagnosis of malignant pleura mesothelioma (MPM) is challenging. Differential diagnosis of MPM versus lung adenocarcinoma (AD) is particularly difficult, yet clinically important since the two neoplasias call for different treatment approaches. Circulating miRNA-profiling to identify miRNAs that can be used to distinguish MPM from AD has not been reported. We conducted a wide screening study of miRNA profiles in serum pools of MPM patients (N = 11), AD patients (N = 36), and healthy subjects (N = 45) to identify non-invasive biomarkers for differential diagnosis of MPM and AD, using deep sequencing. Sequencing detected up to 300 known miRNAs and up to 25 novel miRNAs species in the serum samples. Among known miRNAs, 7 were upregulated in MPM and 12 were upregulated in AD compared to healthy controls. Of these, eight were distinctive for AD and three were unique for MPM. Direct comparison of the miRNA profiles for MPM and AD revealed differences in miRNA levels that could be useful for differential diagnosis. No differentially expressed novel miRNAs were found. Further bioinformatics analysis indicated that three upregulated miRNAs in MPM are associated with the p38 pathway. There are unique alterations in serum miRNAs in MPM and AD compared to healthy controls, as well as differences between MPM and AD profiles. Differing miRNA levels between MPM and AD may be useful for differential diagnosis. A potential association to p38 pathway of three upregulated miRNAs in MPM was revealed

The Balloon-Borne Large Aperture Submillimeter Telescope (BLAST) 2005: A 10 deg^2 Survey of Star Formation in Cygnus X

We present Cygnus X in a new multi-wavelength perspective based on an unbiased BLAST survey at 250, 350, and 500 micron, combined with rich datasets for this well-studied region. Our primary goal is to investigate the early stages of high mass star formation. We have detected 184 compact sources in various stages of evolution across all three BLAST bands. From their well-constrained spectral energy distributions, we obtain the physical properties mass, surface density, bolometric luminosity, and dust temperature. Some of the bright sources reaching 40 K contain well-known compact H II regions. We relate these to other sources at earlier stages of evolution via the energetics as deduced from their position in the luminosity-mass (L-M) diagram. The BLAST spectral coverage, near the peak of the spectral energy distribution of the dust, reveals fainter sources too cool (~ 10 K) to be seen by earlier shorter-wavelength surveys like IRAS. We detect thermal emission from infrared dark clouds and investigate the phenomenon of cold ``starless cores" more generally. Spitzer images of these cold sources often show stellar nurseries, but these potential sites for massive star formation are ``starless" in the sense that to date there is no massive protostar in a vigorous accretion phase. We discuss evolution in the context of the L-M diagram. Theory raises some interesting possibilities: some cold massive compact sources might never form a cluster containing massive stars; and clusters with massive stars might not have an identifiable compact cold massive precursor.Comment: 42 pages, 31 Figures, 6 table

Highlights from the Pierre Auger Observatory

The Pierre Auger Observatory is the world's largest cosmic ray observatory. Our current exposure reaches nearly 40,000 km$^2$ str and provides us with an unprecedented quality data set. The performance and stability of the detectors and their enhancements are described. Data analyses have led to a number of major breakthroughs. Among these we discuss the energy spectrum and the searches for large-scale anisotropies. We present analyses of our X$_{max}$ data and show how it can be interpreted in terms of mass composition. We also describe some new analyses that extract mass sensitive parameters from the 100% duty cycle SD data. A coherent interpretation of all these recent results opens new directions. The consequences regarding the cosmic ray composition and the properties of UHECR sources are briefly discussed.Comment: 9 pages, 12 figures, talk given at the 33rd International Cosmic Ray Conference, Rio de Janeiro 201

The Pierre Auger Observatory III: Other Astrophysical Observations

Astrophysical observations of ultra-high-energy cosmic rays with the Pierre Auger ObservatoryComment: Contributions to the 32nd International Cosmic Ray Conference, Beijing, China, August 201

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

IMPORTANCE: Secretory phospholipase A2(sPLA2) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2inhibitor varespladib has favorable effects on lipid and inflammatory markers; however, its effect on cardiovascular outcomes is unknown. OBJECTIVE: To determine the effects of sPLA2inhibition with varespladib on cardiovascular outcomes. DESIGN, SETTING, AND PARTICIPANTS: A double-blind, randomized, multicenter trial at 362 academic and community hospitals in Europe, Australia, New Zealand, India, and North America of 5145 patients randomized within 96 hours of presentation of an acute coronary syndrome (ACS) to either varespladib (n = 2572) or placebo (n = 2573) with enrollment between June 1, 2010, and March 7, 2012 (study termination on March 9, 2012). INTERVENTIONS: Participants were randomized to receive varespladib (500 mg) or placebo daily for 16 weeks, in addition to atorvastatin and other established therapies. MAIN OUTCOMES AND MEASURES: The primary efficacy measurewas a composite of cardiovascular mortality, nonfatal myocardial infarction (MI), nonfatal stroke, or unstable angina with evidence of ischemia requiring hospitalization at 16 weeks. Six-month survival status was also evaluated. RESULTS: At a prespecified interim analysis, including 212 primary end point events, the independent data and safety monitoring board recommended termination of the trial for futility and possible harm. The primary end point occurred in 136 patients (6.1%) treated with varespladib compared with 109 patients (5.1%) treated with placebo (hazard ratio [HR], 1.25; 95%CI, 0.97-1.61; log-rank P = .08). Varespladib was associated with a greater risk of MI (78 [3.4%] vs 47 [2.2%]; HR, 1.66; 95%CI, 1.16-2.39; log-rank P = .005). The composite secondary end point of cardiovascular mortality, MI, and stroke was observed in 107 patients (4.6%) in the varespladib group and 79 patients (3.8%) in the placebo group (HR, 1.36; 95% CI, 1.02-1.82; P = .04). CONCLUSIONS AND RELEVANCE: In patients with recent ACS, varespladib did not reduce the risk of recurrent cardiovascular events and significantly increased the risk of MI. The sPLA2inhibition with varespladib may be harmful and is not a useful strategy to reduce adverse cardiovascular outcomes after ACS. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01130246. Copyright 2014 American Medical Association. All rights reserved

Responsabilidad social y universidad

182 p.En esta colección se centra en la responsabilidad social que corresponde a las instituciones de educación superior. Así mismo , aporta al compromiso misional de la universidad de inculturar la doctrina social católica y el estudio, análisis, sensibilización y propuestas frente a las realidades culturales, políticas, económicas y sociales de Colombia. Esta obra está destinada a las comunidades académicas que orientan sus reflexiones a la proyección social de sus entes educativos.Prólogo Responsabilidad social universitaria 1· Humanizar el hábitat. Un ejemplo de responsabilidad social William Fernando Puentes González 2. Una introducción a la idea de justicia. Un debate contemporáneo ¿qué es una sociedad justa? Armando Rojas Claros 3. Acercamiento al personalismo de Emmanuel Mounier como propuesta ante la problemática de la sociedad actual Alexander Aldana Piñeros 4. La cortesía, expresión de la responsabilidad social Edilberto Cruz Espejo 5. Construcción de ciudadanía y de ciudadano: la formación del profesional incluyente Edgar Javier Garzón P. 6. Evaluación e impacto de un programa de formación humanística en instituciones educativas de la ciudad de Bogotá Katherin Hurtado Morales, Humberto Grimaldo Durán, Floralba Barrero Rivera y Alba Lucía Meneses Báez 7. Caritas in veritate: verdad y acción, un paso a la responsabilidad social en el mundo globalizado Elizabeth Duvanca Reyes 8. Doctrina Social de la Iglesia y desarrollo humano: ejemplo de responsabilidad social Giovanni Reyes Ortiz 9. La responsabilidad social universitaria desde el paradigma de la psicología comunitaria Nelly Ayala Rodríguez María Constanza del Portillo Obando María Victoria Neira Roa 10. Informática comunitaria y acciones de mejoramiento para la proyección social Jorge Fernando Bejarano Lobo 11. Responsabilidad social en la educación matemática Jacinto Eloy Puig Portal 12. Responsabilidad social. Recuento de experiencias Doris Carda de Bernal Bibliografí